Regulatory guidelines for adoption of in silico models in drug development
The VPHi is leading a working group in collaboration with representatives of EMA and a number of experts from different fields to identify the most appropriate tools for verifying and validating in silico models in drug development.
Post-doc on Scalability of in silico medicine models at University of Bologna
InSilc project promoted by the European Commission
The European Commission has published an article promoting the EU-funded InSilc project aiming to create an in silico clinical trials platform for designing and developing drug-eluting BVS
Credibility of In Silico Trial Technologies
A new interesting position paper has been published by Prof Viceconti and all on the credibility of predictive models and the regulatory science aspects of in silico medicine. A must read for anyone working in the field!